CORC

在结果中检索

CORC

浏览/检索结果: 共47条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
METHOD FOR PREPARATION OF ATTAPULGITE-BASED PH-RESPONSIVE ANTIBACTERIAL MATERIAL 专利
专利号: US 11,700,849 B2, 申请日期: 2023-07-18,
作者:  Aiqin Wang;  Aiping Hui;  Fangfang Yang;  Yuru Kang;  Bin Mu
收藏  |  浏览/下载：1/0  |  提交时间：2023/12/13
Reduced Gray Matter Volume in Orbitofrontal Cortex Across Schizophrenia, Major Depressive Disorder, and Bipolar Disorder: A Comparative Imaging Study 期刊论文
FRONTIERS IN NEUROSCIENCE, 2022, 卷号: 16, 页码: 8
作者:  Yang, Yongfeng;  Li, Xue;  Cui, Yue;  Liu, Kang;  Qu, Haoyang
收藏  |  浏览/下载：26/0  |  提交时间：2022/07/25
Preparation and antibacterial properties of Carvacrol-loaded composite microcapsules via palygorskite-stabilized Pickering emulsions 期刊论文
Clays and Clay Minerals, 2022, 卷号: 70, 期号: 0, 页码: 527–538.
作者:  Aiping Hui,;  Yongfeng Zhu;  Fangfang Yang;  Yuru Kang;  Aiqin Wang
收藏  |  浏览/下载：6/0  |  提交时间：2022/12/09
Preparation and properties of antibacterial polyhexamethylene biguanide/palygorskite composites as zearalenone adsorbent 期刊论文
Clays and Clay Minerals, 2022, 卷号: 70, 期号: 0, 页码: 182-195
作者:  Yuru Kang;  Bin Mu;  Gong Zhu;  Yongfeng Zhu;  Aiqin Wang
收藏  |  浏览/下载：0/0  |  提交时间：2022/12/09
Dependence of Field Splitting Characteristics on Metallic Components Topological Configuration in Multilaminar Plasmonic Films 期刊论文
IEEE Transactions on Nanotechnology, 2021, 卷号: 20, 页码: 715-725
作者:  Kang, Yifan;  Yang, Hongtao;  Wang, Chao
收藏  |  浏览/下载：18/0  |  提交时间：2021/10/11
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  Gong, Guozhong;  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun
收藏  |  浏览/下载：56/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：45/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace